Home
LGND
LGND News

Latest Ligand Pharmaceuticals Incorporated (LGND) News on July 27, 2024

Argus Research

3 days ago

LGND: Raising target price to $107.00

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Business Wire

3 days ago

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Argus Research

10 days ago

LGND: Raising target price to $104.00

Argus Research

17 days ago

LGND: Raising target price to $96.00

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

Pharmaceutical Technology

18 days ago

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

MT Newswires

19 days ago

Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties

Ligand to buy Apeiron; Roche reports another TIGIT setback

BioPharma Dive

19 days ago

Ligand to buy Apeiron; Roche reports another TIGIT setback

Ligand to Acquire APEIRON Biologics AG for $100 Million

Business Wire

19 days ago

Ligand to Acquire APEIRON Biologics AG for $100 Million

Argus Research

24 days ago

LGND: Raising target price to $89.00

Lifecore Biomedical Announces Cooperation Agreement with 22NW

GlobeNewswire

a month ago

Lifecore Biomedical Announces Cooperation Agreement with 22NW

MT Newswires

a month ago

Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Business Wire

a month ago

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

Zacks

a month ago

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?

Zacks

a month ago

Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?

Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

Zacks

a month ago

Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable

Simply Wall St.

a month ago

The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable

MT Newswires

a month ago

Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

Business Wire

a month ago

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

Zacks

a month ago

Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

Zacks

a month ago

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

Zacks

a month ago

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

Zacks

a month ago

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

What Makes Ligand (LGND) a New Strong Buy Stock

Zacks

a month ago

What Makes Ligand (LGND) a New Strong Buy Stock

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?

Zacks

2 months ago

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?

Zacks

2 months ago

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?

Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why

Zacks

2 months ago

Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why

Ligand to Participate in Upcoming Investor Conferences

Business Wire

2 months ago

Ligand to Participate in Upcoming Investor Conferences

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

Zacks

2 months ago

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

Zacks

2 months ago

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

Zacks

2 months ago

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

Zacks

2 months ago

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Zacks

2 months ago

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Zacks

2 months ago

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Ionis (IONS), Biogen Down on Ending Development of ALS Drug

Zacks

2 months ago

Ionis (IONS), Biogen Down on Ending Development of ALS Drug

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks

2 months ago

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Zacks

2 months ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...

GuruFocus.com

2 months ago

Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Zacks

2 months ago

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Zacks

2 months ago

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Zacks

2 months ago

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Zacks

2 months ago

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales

Zacks

2 months ago

Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales

MT Newswires

2 months ago

Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing

Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade

Zacks

2 months ago

Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine

Zacks

2 months ago

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

Zacks

2 months ago

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Zacks

3 months ago

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

Zacks

3 months ago

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Zacks

3 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

3 months ago

Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Zacks

3 months ago

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

Zacks

3 months ago

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?

Zacks

3 months ago

Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?

Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)

Simply Wall St.

3 months ago

Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Zacks

3 months ago

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

MT Newswires

3 months ago

Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Zacks

3 months ago

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates

Zacks

3 months ago

Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Zacks

3 months ago

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Zacks

3 months ago

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

GuruFocus.com

3 months ago

Ligand Pharmaceuticals Inc (LGND) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...

GuruFocus.com

3 months ago

Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Agenus Inc Earnings Call

Ligand Pharmaceuticals Inc (LGND) Reports Mixed Q1 2024 Results: Misses Revenue Estimates but ...

GuruFocus.com

3 months ago

Ligand Pharmaceuticals Inc (LGND) Reports Mixed Q1 2024 Results: Misses Revenue Estimates but ...

Agenus (AGEN) Q1 2024 Earnings Call Transcript

Motley Fool

3 months ago

Agenus (AGEN) Q1 2024 Earnings Call Transcript

Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates

Zacks

3 months ago

Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates

Associated Press Finance

3 months ago

Ligand: Q1 Earnings Snapshot

Ligand Reports First Quarter 2024 Financial Results

Business Wire

3 months ago

Ligand Reports First Quarter 2024 Financial Results

MT Newswires

3 months ago

Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading

MT Newswires

3 months ago

Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Zacks

3 months ago

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Zacks

3 months ago

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Business Wire

3 months ago

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand

Zacks

3 months ago

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand

Don't Overlook These Top Medical Stocks as Q1 Earnings Approach

Zacks

3 months ago

Don't Overlook These Top Medical Stocks as Q1 Earnings Approach

5 Biotech Stocks Worth Adding to Your Portfolio in 2024

Zacks

3 months ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2024

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

Zacks

3 months ago

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks

3 months ago

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates

Zacks

3 months ago

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates

Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

Zacks

3 months ago

Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

Zacks

3 months ago

Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Zacks

3 months ago

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Argus Research

3 months ago

LGND: Lowering target price to $73.00

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024

Business Wire

3 months ago

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024

Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know

Zacks

3 months ago

Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know

Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why

Zacks

3 months ago

Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why

Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study

Zacks

3 months ago

Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Zacks

3 months ago

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Vincerx (VINC) Tumbles on Results From Cancer Therapy Study

Zacks

4 months ago

Vincerx (VINC) Tumbles on Results From Cancer Therapy Study

Corcept (CORT) Completes Enrollment in Ovarian Cancer Study

Zacks

4 months ago

Corcept (CORT) Completes Enrollment in Ovarian Cancer Study

Palatin (PTN) Up 15% on Results From Dry Eye Disease Study

Zacks

4 months ago

Palatin (PTN) Up 15% on Results From Dry Eye Disease Study

Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Simply Wall St.

4 months ago

Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why

Zacks

4 months ago

Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why

Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference

Business Wire

4 months ago

Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

Zacks

4 months ago

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts

Zacks

4 months ago

Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts

Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Zacks

4 months ago

Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Share on Social Networks: